Clinical Trials Directory

Trials / Sponsors / Shanghai Huaota Biopharmaceutical Co., Ltd.

Shanghai Huaota Biopharmaceutical Co., Ltd.

Industry · 16 registered clinical trials11 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingA Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris.
Acne Vulgaris
Phase 1 / Phase 22026-03-27
Not Yet RecruitingPhase III Clinical Study of HB0025 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy
Squamous Non-small Cell Lung Cancer
Phase 32026-01-15
Not Yet RecruitingPhase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy a
Non Squamous Non-small Cell Lung Cancer
Phase 32026-01-15
RecruitingA Study to Evaluate Single-dose of HB0043 in Healthy Adult Participants
Healthy
Phase 12025-06-03
RecruitingEfficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.
Hidradenitis Suppurativa
Phase 1 / Phase 22025-03-19
RecruitingA Study to Evaluate HB0034 in Healthy Chinese Adult Participants
Healthy
Phase 12024-12-06
RecruitingA Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants
Healthy
Phase 12024-11-18
RecruitingLong-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis
Generalized Pustular Psoriasis
Phase 2 / Phase 32024-09-02
Enrolling By InvitationA Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors
Solid Tumors
Phase 1 / Phase 22024-09-01
RecruitingEfficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)
Generalized Pustular Psoriasis (GPP)
Phase 22024-02-29
UnknownA Study of HB0045 Injection in Patients With Advanced Solid Tumors
Solid Tumor, Adult
Phase 1 / Phase 22023-07-18
CompletedHB0034 in Patients With Generalized Pustular Psoriasis (GPP)
Generalized Pustular Psoriasis
Phase 12022-11-06
CompletedA Study to Evaluate Multi-dose of HB0034 in Healthy Adult Participants
Healthy
Phase 12022-10-13
UnknownA Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors
Advanced Solid Tumor, Cervical Cancer
Phase 1 / Phase 22022-09-09
RecruitingA Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors
Advanced Solid Tumor, NSCLC
Phase 1 / Phase 22022-08-25
CompletedA Study to Evaluate HB0034 in Healthy Adult Participants
Healthy
Phase 12021-12-03